Design for Peptide DeliverySM

 

  • Assess drug delivery compatibility of a peptide
  • Screen peptides for drug delivery
  • Match peptide properties with proven
    drug delivery technologies
  • Launch products sooner by
    decreasing development time

 

Proven drug delivery technologies are prefered for future products because these technologies have gone through the rigors of regulatory review, manufacturing, and market acceptance. To target proven drug delivery technologies, the SurModics Pharmaceuticals - Genzyme team performs drug-delivery-based preformulation screening on lead peptides in discovery. Additionally, the SurModics Pharmaceuticals - Genzyme team optimizes candidate peptides for long-acting parenteral delivery. <Click here for more details>

 


Events

BioPartnering North America
27 February - 1 March 2011
Vancouver, BC, Canada

BIO-Europe Spring
14-16 March 2011
Milan, Italy

ARVO
1-5 May 2011
Fort Lauderdale, FL
SurModics Booth 619

 

News

Webinar Archive: Screening Peptides for Extended Release

 

Genzyme Pharmaceuticals and SurModics Pharmaceuticals Enter Broad Collaboration